SEARCH WITHIN CONTENT
Citation Information : Immunohematology. Volume 6, Issue 3, Pages 53-58, DOI: https://doi.org/10.21307/immunohematology-2019-1041
License : (Transfer of Copyright)
Published Online: 20-December-2020
Monoclonal antibodies, capable of detecting monomorphic epitopes on HLA class I polypeptides and beta-microglobulin (ß2-M), have been used by a variety of techniques to ascertain the type of structure detected on red blood cells (RBCs). Hemagglutinatlon with class I monoclonal antibodies confirmed the reported relationship between Bg blood groups and HLA. It also established that the expression of HLA on RBCs which do not have nuclei is not normally strong, hut may be enhanced in patients, notably those with systemic lupus erythematosus (SLE). Estimates of the number of class I molecules on mature RBCs by a radioligand-binding assay have confirmed that all HLA-B7 (Bga) individuals have higher numbers but that SLE patients usually have the most (1240/RBC). Class I polypeptides were not elevated in the plasm of SLE patients and all RBCs lost molecules on aging in the circulation. These two facts suggest that HLA on RBCs is not acquired from plasma. When RBCs from SLE patients were immunoblotted with monoclonal antibodies, a complete 45 kDa intrinsic transmembrane heavy chain of HLA class I and a light chain of 11 kDa (ß2-M) were detected. Chloroquine treatment and acid elution of RBCs did not remove HLA class I but only ß2-M. As most antibodies recognize epitopes that depend on close association of dass I with ß2-M, the lost reactivity of treated RBCs may be understood.